Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387473451> ?p ?o ?g. }
- W4387473451 abstract "Although cytarabine (AraC) has greatly contributed to improving the prognosis of patients with acute myeloid leukemia (AML), many patients developed drug resistance and eventually succumbed to AML. Thus, resistance to AraC is a major obstacle to improve the efficacy of chemotherapy in AML. Hence, this study aimed to demonstrate that artesunate (ART) can reliably induce cell death in vitro and block AraC resistance.AML cell lines resistant to AraC were first constructed by repeated dosing for 5 months. Further, we analyzed whether ART intervention affected the sensitivity of AraC-resistant cells to AraC by cell function experiments, mainly including CCK-8 to assess cell viability, flow cytometry to examine apoptosis, and Western blotting to measure the Janus kinase (JAK)/signal transducers and activators of transcription 3 (STAT3) pathway protein expression. Furthermore, whether JAK/STAT3 pathway knockdown has a blocking effect on the efficacy of ART was also assessed.Co-treatment of ART and AraC increased the sensitivity of AML cells to AraC. Also, it effectively reversed the resistance of AML cells to AraC that is shown by the significantly reduced proliferation and increased apoptosis rates. ART intervention suppressed the activation of the JAK/STAT3 signaling pathway in AraC-resistant AML cells, suggesting that the function of ART in reversing AraC resistance is indeed dependent on the JAK/STAT3 signaling pathway.In summary, ART enhanced the sensitivity of AML/AraC-resistant cells to AraC by modulating the JAK/STAT3 pathway." @default.
- W4387473451 created "2023-10-11" @default.
- W4387473451 creator A5033832592 @default.
- W4387473451 creator A5037458498 @default.
- W4387473451 creator A5055151897 @default.
- W4387473451 creator A5062863345 @default.
- W4387473451 creator A5082112041 @default.
- W4387473451 creator A5086275760 @default.
- W4387473451 date "2023-10-10" @default.
- W4387473451 modified "2023-10-12" @default.
- W4387473451 title "Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling" @default.
- W4387473451 cites W1995821070 @default.
- W4387473451 cites W2042520699 @default.
- W4387473451 cites W2053688397 @default.
- W4387473451 cites W2110790636 @default.
- W4387473451 cites W2119028586 @default.
- W4387473451 cites W2169302611 @default.
- W4387473451 cites W2288260164 @default.
- W4387473451 cites W2344022151 @default.
- W4387473451 cites W2583934405 @default.
- W4387473451 cites W2593768764 @default.
- W4387473451 cites W2757324382 @default.
- W4387473451 cites W2786987313 @default.
- W4387473451 cites W2886808350 @default.
- W4387473451 cites W2913532930 @default.
- W4387473451 cites W2946710419 @default.
- W4387473451 cites W2981681370 @default.
- W4387473451 cites W3005295900 @default.
- W4387473451 cites W3026785246 @default.
- W4387473451 cites W3029806102 @default.
- W4387473451 cites W3033124631 @default.
- W4387473451 cites W3045082028 @default.
- W4387473451 cites W3087856225 @default.
- W4387473451 cites W3112936653 @default.
- W4387473451 cites W3130903278 @default.
- W4387473451 cites W3163483547 @default.
- W4387473451 cites W3195237214 @default.
- W4387473451 cites W3195533486 @default.
- W4387473451 cites W4210495883 @default.
- W4387473451 cites W4214895922 @default.
- W4387473451 cites W4220661115 @default.
- W4387473451 cites W4224258242 @default.
- W4387473451 cites W4281567773 @default.
- W4387473451 cites W4291170595 @default.
- W4387473451 cites W4293776726 @default.
- W4387473451 cites W4302763952 @default.
- W4387473451 cites W4306638484 @default.
- W4387473451 cites W4360599879 @default.
- W4387473451 doi "https://doi.org/10.1080/16078454.2023.2255802" @default.
- W4387473451 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37815490" @default.
- W4387473451 hasPublicationYear "2023" @default.
- W4387473451 type Work @default.
- W4387473451 citedByCount "0" @default.
- W4387473451 crossrefType "journal-article" @default.
- W4387473451 hasAuthorship W4387473451A5033832592 @default.
- W4387473451 hasAuthorship W4387473451A5037458498 @default.
- W4387473451 hasAuthorship W4387473451A5055151897 @default.
- W4387473451 hasAuthorship W4387473451A5062863345 @default.
- W4387473451 hasAuthorship W4387473451A5082112041 @default.
- W4387473451 hasAuthorship W4387473451A5086275760 @default.
- W4387473451 hasBestOaLocation W43874734511 @default.
- W4387473451 hasConcept C112392421 @default.
- W4387473451 hasConcept C11960822 @default.
- W4387473451 hasConcept C157333092 @default.
- W4387473451 hasConcept C2776414213 @default.
- W4387473451 hasConcept C2778041864 @default.
- W4387473451 hasConcept C2778729363 @default.
- W4387473451 hasConcept C2778923194 @default.
- W4387473451 hasConcept C2779282312 @default.
- W4387473451 hasConcept C42362537 @default.
- W4387473451 hasConcept C502942594 @default.
- W4387473451 hasConcept C62478195 @default.
- W4387473451 hasConcept C71924100 @default.
- W4387473451 hasConcept C86803240 @default.
- W4387473451 hasConcept C95444343 @default.
- W4387473451 hasConcept C98175054 @default.
- W4387473451 hasConcept C98274493 @default.
- W4387473451 hasConceptScore W4387473451C112392421 @default.
- W4387473451 hasConceptScore W4387473451C11960822 @default.
- W4387473451 hasConceptScore W4387473451C157333092 @default.
- W4387473451 hasConceptScore W4387473451C2776414213 @default.
- W4387473451 hasConceptScore W4387473451C2778041864 @default.
- W4387473451 hasConceptScore W4387473451C2778729363 @default.
- W4387473451 hasConceptScore W4387473451C2778923194 @default.
- W4387473451 hasConceptScore W4387473451C2779282312 @default.
- W4387473451 hasConceptScore W4387473451C42362537 @default.
- W4387473451 hasConceptScore W4387473451C502942594 @default.
- W4387473451 hasConceptScore W4387473451C62478195 @default.
- W4387473451 hasConceptScore W4387473451C71924100 @default.
- W4387473451 hasConceptScore W4387473451C86803240 @default.
- W4387473451 hasConceptScore W4387473451C95444343 @default.
- W4387473451 hasConceptScore W4387473451C98175054 @default.
- W4387473451 hasConceptScore W4387473451C98274493 @default.
- W4387473451 hasFunder F4320321001 @default.
- W4387473451 hasFunder F4320322272 @default.
- W4387473451 hasFunder F4320326294 @default.
- W4387473451 hasIssue "1" @default.
- W4387473451 hasLocation W43874734511 @default.
- W4387473451 hasLocation W43874734512 @default.
- W4387473451 hasOpenAccess W4387473451 @default.